Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F de Braud

Showing results (71-80 of 140) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) GroupE Bajetta, M Di Bartolomeo, F de Braud, et al.
British Journal of Cancer|February 1, 1996
Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysisF Janot, J Klijanienko, A Russo, et al.
Psycho-Oncology|October 15, 2013
The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory studyC Catania, D Radice, G Spitaleri, et al.
Acta Bio-Medica De L'Ateneo Parmense : Organo Della Societa Di Medicina E Scienze Naturali Di Parma|January 1, 1984
[Analysis of the enzyme terminal deoxyribonucleotidyl transferase in lymphoma and leukemia cells]E Bombardieri, F Campagnari, F De Braud, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2012
Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patientsF Pietrantonio, P Biondani, M Milione, et al.
The International Journal of Biological Markers|October 26, 2005
Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational studyA Leon, M Torta, R Dittadi, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2008
Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR-positive advanced colorectal cancer treated with gefitinib?M G Zampino, E Magni, L Santoro, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of deviceR Biffi, F Corrado, F de Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2005
Breast cancer vaccines: a clinical reality or fairy tale?G Curigliano, G Spitaleri, E Pietri, et al.
Anticancer Research|November 20, 2001
Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysisG Curigliano, G Ferretti, G Flamini, et al.
Pageof 14

Showing results (71-80 of 140) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) GroupE Bajetta, M Di Bartolomeo, F de Braud, et al.
British Journal of Cancer|February 1, 1996
Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysisF Janot, J Klijanienko, A Russo, et al.
Psycho-Oncology|October 15, 2013
The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory studyC Catania, D Radice, G Spitaleri, et al.
Acta Bio-Medica De L'Ateneo Parmense : Organo Della Societa Di Medicina E Scienze Naturali Di Parma|January 1, 1984
[Analysis of the enzyme terminal deoxyribonucleotidyl transferase in lymphoma and leukemia cells]E Bombardieri, F Campagnari, F De Braud, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2012
Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patientsF Pietrantonio, P Biondani, M Milione, et al.
The International Journal of Biological Markers|October 26, 2005
Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational studyA Leon, M Torta, R Dittadi, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2008
Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR-positive advanced colorectal cancer treated with gefitinib?M G Zampino, E Magni, L Santoro, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of deviceR Biffi, F Corrado, F de Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2005
Breast cancer vaccines: a clinical reality or fairy tale?G Curigliano, G Spitaleri, E Pietri, et al.
Anticancer Research|November 20, 2001
Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysisG Curigliano, G Ferretti, G Flamini, et al.
Pageof 14